Brain mitochondrial nitric oxide synthase: in vitro and in vivo inhibition by chlorpromazine

Silvia Lores-Arnaiz1, Gabriela D'Amico, Analía Czerniczyniec

  • 1Laboratory of Free Radical Biology, School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. slarnaiz@ffyb.uba.ar

Insights

Chlorpromazine inhibits mouse brain mitochondrial nitric oxide synthase (mtNOS) activity. This inhibition enhances mitochondrial respiration and reduces hydrogen peroxide production, suggesting a key role for mtNOS in regulating mitochondrial function.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Mitochondrial Biology

Background:

  • Mitochondria possess nitric oxide synthase (mtNOS) in the mouse brain.
  • mtNOS activity is regulated and influences mitochondrial function.

Purpose of the Study:

  • To investigate the effect of chlorpromazine on mouse brain mtNOS activity.
  • To determine the impact of chlorpromazine-induced mtNOS inhibition on mitochondrial respiration and hydrogen peroxide production.

Main Methods:

  • Enzymatic assays to measure mtNOS activity.
  • Mitochondrial respiration studies using various substrates.
  • Hydrogen peroxide (H2O2) production measurements.
  • In vitro and in vivo administration of chlorpromazine and related compounds.

Main Results:

  • Chlorpromazine directly inhibited mtNOS activity in vitro (IC50 = 2.0 microM).
  • Mitochondria from chlorpromazine-treated mice showed 48% reduced mtNOS activity.
  • Inhibition of mtNOS led to increased state 3 respiration and decreased H2O2 production.
  • The regulatory effects of mtNOS on respiration and H2O2 were diminished by chlorpromazine.

Conclusions:

  • Chlorpromazine effectively inhibits mouse brain mtNOS activity both in vitro and in vivo.
  • mtNOS plays a regulatory role in mitochondrial respiration and H2O2 production.
  • Chlorpromazine's effects on mitochondria are mediated, at least in part, by mtNOS inhibition.